Doctor profile · Federal record
Dr. Yusuf Qamruzzaman, MD
Hematology & Oncology Physician (CMS: Hematology/Oncology) · Royal Oak, MI
- NPI 1174738231
- Accepts Medicare
- 19 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
3577 W 13 Mile Road Ste 103
Royal Oak, MI 48073
(313) 274-1800
fax (313) 769-6285 - Mailing address
-
3577 W. 13 Mile Road Ste 103
Royal Oak, MI 48073
Credentials & registration
- NPI registered
- May 2007 — 19 yrs on file
- Profile last updated
- April 12, 2022
- Year of graduation
- 2007 — 19 yrs since
- Specialty taxonomy
- 207RH0003X — NUCC code
- State license (1)
- Michigan #4301104226
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1174738231. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
58,024
Distinct HCPCS
10
Medicare allowed
$477,521
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
Q5110 |
Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram | 17,880 | 22 | $0 | |
Q0138 |
Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | 12,750 | 21 | $0 | |
J9264 |
Injection, paclitaxel protein-bound particles, 1 mg | 5,500 | 12 | $13 | |
J1453 |
Injection, fosaprepitant, 1 mg | 4,200 | 13 | $0 | |
J0897 |
Injection, denosumab, 1 mg | 3,840 | 18 | $23 | |
J9041 |
Injection, bortezomib, 0.1 mg | 2,310 | 12 | $6 | |
J0885 |
Injection, epoetin alfa, (for non-esrd use), 1000 units | 1,760 | 24 | $7 | |
36415 |
Insertion of needle into vein for collection of blood sample | 1,219 | 448 | $8 | |
85025 |
Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 1,188 | 437 | $8 | |
J2469 |
Injection, palonosetron hcl, 25 mcg | 930 | 40 | $1 |
In context: peer comparison
Among 8 peers in Royal Oak Hematology & Oncology Physician, average services per provider: 1,850. This provider delivers 31× the peer median.Open Payments
Industry payments received
All-time total
$777
Transactions
31
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | 6 | $96.95 | |
| Daiichi Sankyo INC. | 3 | $65.76 | |
| Genmab U.S., INC. | 2 | $49.39 | |
| Janssen Biotech, INC. | 2 | $44.52 | |
| Astellas Pharma US INC | 3 | $44.44 | |
| Mirati Therapeutics, INC. | 2 | $43.14 | |
| Kite Pharma, INC. | 2 | $40.67 | |
| Abbvie INC. | 2 | $37.13 | |
| GlaxoSmithKline, LLC. | 2 | $36.16 | |
| Eisai INC. | 2 | $35.28 | |
| Takeda Pharmaceuticals U.S.A., INC. | 1 | $32.27 | |
| Taiho Oncology, INC. | 1 | $23.59 | |
| Puma Biotechnology, INC. | 1 | $22.84 | |
| Rigel Pharmaceuticals, INC. | 1 | $22.66 | |
| Janssen Pharmaceuticals, INC | 1 | $22.00 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
669
Patients
174
Total drug cost
$943,780
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Eliquis (Apixaban) | Brand | 98 | 28 | $115,838 |
| Letrozole | Generic | 91 | 25 | $2,879 |
| Prednisone | Generic | 68 | 24 | $768 |
| Dexamethasone | Generic | 56 | 19 | $1,220 |
| Anastrozole | Generic | 52 | 13 | $1,219 |
| Prochlorperazine Maleate | Generic | 44 | 34 | $1,958 |
| Imbruvica (Ibrutinib) | Brand | 40 | 0 | $643,035 |
| Abiraterone Acetate | Generic | 37 | 0 | $172,269 |
| Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen) | Brand | 34 | 17 | $877 |
| Hydroxyurea | Generic | 31 | 0 | $1,162 |
Hospital affiliations
Frequently asked questions
What is Dr. Yusuf Qamruzzaman's medical specialty?
Dr. Yusuf Qamruzzaman practices Hematology & Oncology Physician in Royal Oak, MI.
Where does Dr. Yusuf Qamruzzaman practice?
Dr. Yusuf Qamruzzaman practices at 3577 W 13 Mile Road Ste 103, Royal Oak, MI 48073. Office phone: 3132741800.
What is Dr. Yusuf Qamruzzaman's NPI?
Dr. Yusuf Qamruzzaman's National Provider Identifier (NPI) is 1174738231, issued by NPPES.
Does Dr. Yusuf Qamruzzaman accept Medicare assignment?
Yes. Dr. Yusuf Qamruzzaman accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Yusuf Qamruzzaman commonly perform?
Top Medicare-reported procedures in 2023: Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram (HCPCS Q5110); Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS Q0138); Injection, paclitaxel protein-bound particles, 1 mg (HCPCS J9264). Source: CMS Medicare Physician & Other Practitioners file.